UK markets open in 5 hours 15 minutes
NIKKEI 225
38,257.69 +55.32 (+0.14%) HANG SENG
18,333.44 +19.58 (+0.11%) CRUDE OIL
79.29 +0.30 (+0.38%) GOLD FUTURES
2,318.80 -3.50 (-0.15%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,171.49 -901.21 (-1.80%)
Apellis Pharmaceuticals Inc (1JK.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 09:32PM CEST
| Previous close | 44.96 |
| Open | 41.02 |
| Bid | 39.71 x N/A |
| Ask | 39.96 x N/A |
| Day's range | 39.64 - 41.02 |
| 52-week range | 18.70 - 87.00 |
| Volume | |
| Avg. volume | 32 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 29 Jul 2024 - 02 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Insider MonkeyApellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q1 2024 Earnings Call Transcript
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q1 2024 Earnings Call Transcript May 7, 2024 Apellis Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.54 EPS, expectations were $-0.54. Apellis Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good […]
Simply Wall St.Apellis Pharmaceuticals First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Apellis Pharmaceuticals ( NASDAQ:APLS ) First Quarter 2024 Results Key Financial Results Revenue: US$172.3m (up 284...
- GuruFocus.com
Apellis Pharmaceuticals Inc (APLS) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue ...
Discover how Apellis Pharmaceuticals Inc navigated Q1 2024 with significant revenue increases and strategic advancements despite competitive challenges.
© 2024 Yahoo. All rights reserved.